IFP Advisors’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.5K | Sell |
796
-18
| -2% | -$260 | ﹤0.01% | 3307 |
|
|
2026
Q1 | $11.8K | Sell |
814
-222
| -21% | -$3.18K | ﹤0.01% | 3074 |
|
|
2025
Q4 | $14.8K | Buy |
1,036
+822
| +384% | +$8.07K | ﹤0.01% | 2872 |
|
|
2025
Q3 | $1.69K | Buy |
214
+49
| +30% | +$349 | ﹤0.01% | 3768 |
|
|
2025
Q2 | $1.32K | Sell |
165
-11,546
| -99% | -$74.5K | ﹤0.01% | 4097 |
|
|
2025
Q1 | $95.6K | Sell |
11,711
-239
| -2% | -$2.21K | ﹤0.01% | 1553 |
|
|
2024
Q4 | $113K | Sell |
11,950
-875
| -7% | -$9.1K | ﹤0.01% | 1411 |
|
|
2024
Q3 | $137K | Sell |
12,825
-9,695
| -43% | -$106K | ﹤0.01% | 1273 |
|
|
2024
Q2 | $223K | Buy |
22,520
+208
| +0.9% | +$2.13K | 0.01% | 991 |
|
|
2024
Q1 | $263K | Buy |
22,312
+684
| +3% | +$8.75K | 0.01% | 865 |
|
|
2023
Q4 | $307K | Buy |
21,628
+1,525
| +8% | +$17.3K | 0.01% | 760 |
|
|
2023
Q3 | $244K | Sell |
20,103
-15,278
| -43% | -$197K | 0.01% | 874 |
|
|
2023
Q2 | $444K | Sell |
35,381
-409
| -1% | -$4.85K | 0.02% | 697 |
|
|
2023
Q1 | $591K | Sell |
35,790
-1,184
| -3% | -$14.6K | 0.03% | 542 |
|
|
2022
Q4 | $610K | Buy |
36,974
+5,381
| +17% | +$60.6K | 0.02% | 806 |
|
|
2022
Q3 | $519K | Buy |
31,593
+806
| +3% | +$8.98K | 0.01% | 912 |
|
|
2022
Q2 | $505K | Hold |
30,787
| – | – | 0.02% | 850 |
|
|
2022
Q1 | $505K | Buy |
30,787
+18,096
| +143% | +$170K | 0.02% | 850 |
|
|
2021
Q4 | $143K | Buy |
12,691
+2,091
| +20% | +$23.3K | ﹤0.01% | 1111 |
|
|
2021
Q3 | $102K | Sell |
10,600
-1,578
| -13% | -$16.1K | ﹤0.01% | 1289 |
|
|
2021
Q2 | $118K | Buy |
12,178
+198
| +2% | +$1.93K | ﹤0.01% | 1161 |
|
|
2021
Q1 | $119K | Buy |
11,980
+11,268
| +1,583% | +$174K | ﹤0.01% | 1089 |
|
|
2020
Q4 | $15K | Buy |
712
+558
| +362% | +$11.4K | ﹤0.01% | 1898 |
|
|
2020
Q3 | $2K | Buy |
+154
| New | +$2.25K | ﹤0.01% | 2474 |
|
|
2019
Q1 | – | Sell |
-21
| Closed | – | – | 2714 |
|
|
2018
Q4 | $0 | Hold |
21
| – | – | ﹤0.01% | 3645 |
|
|
2018
Q3 | $0 | Sell |
21
-69
| -77% | -$965 | ﹤0.01% | 3890 |
|
|
2018
Q2 | $1K | Buy |
90
+69
| +329% | +$1.04K | ﹤0.01% | 3719 |
|
|
2018
Q1 | $0 | Hold |
21
| – | – | ﹤0.01% | 3774 |
|
|
2017
Q4 | $0 | Sell |
21
-1,200
| -98% | -$16.5K | ﹤0.01% | 3899 |
|
|
2017
Q3 | $18K | Sell |
1,221
-979
| -45% | -$13K | ﹤0.01% | 2662 |
|
|
2017
Q2 | $22K | Buy |
+2,200
| New | +$17.7K | ﹤0.01% | 2519 |
|
|
2016
Q4 | – | Sell |
-200
| Closed | -$1K | – | 4032 |
|
|
2016
Q3 | $1K | Hold |
200
| – | – | ﹤0.01% | 3718 |
|
|
2016
Q2 | $1K | Buy |
+200
| New | +$1.4K | ﹤0.01% | 3612 |
|
IFP Advisors's FOLD Position: Q2 2026 in Review
IFP Advisors reduced its Amicus Therapeutics (FOLD) stake by 2.2% in Q2 2026, selling an estimated $260 and leaving 796 shares worth $11.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3307.
IFP Advisors first reported a position in FOLD in Q2 2016 and has held it in 33 quarters since. The position peaked at $610K in Q4 2022. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.
- IFP Advisors held 796 shares of Amicus Therapeutics worth $11.5K as of Q2 2026.
- IFP Advisors sold 18 Amicus Therapeutics shares in Q2 2026, an estimated $260.
- Amicus Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3307 holding.
- IFP Advisors first reported a position in Amicus Therapeutics in Q2 2016 and has held it in 33 quarters since.
- IFP Advisors's Amicus Therapeutics position peaked at $610K in Q4 2022.
- 1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.